These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease. Chang CT; Yang CY; Tsai FJ; Lin SY; Chen CJ Biomed Res Int; 2015; 2015():164846. PubMed ID: 26090384 [TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634 [TBL] [Abstract][Full Text] [Related]
11. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease. Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356 [TBL] [Abstract][Full Text] [Related]
12. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids. Gao D; Podrez EA Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052 [TBL] [Abstract][Full Text] [Related]
13. Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease. Chang CT; Shen MY; Hsieh JY; Chang CM; Liao HY; Chen FY; Hsu CY; Yang CY; Chen CJ Atherosclerosis; 2018 Nov; 278():147-155. PubMed ID: 30278357 [TBL] [Abstract][Full Text] [Related]
14. An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients. Seraglia R; Sartore G; Marin R; Burlina S; Manzato E; Ragazzi E; Traldi P; Lapolla A J Mass Spectrom; 2013 Jan; 48(1):105-10. PubMed ID: 23303753 [TBL] [Abstract][Full Text] [Related]
15. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517 [TBL] [Abstract][Full Text] [Related]
17. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity. Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892 [TBL] [Abstract][Full Text] [Related]
18. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis. Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function. Lv P; Zhao M; Liu Y; Jin H; Cui W; Fan C; Teng Y; Zheng L; Huang Y Int J Mol Med; 2018 Jan; 41(1):61-68. PubMed ID: 29115584 [TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction. Sartore G; Seraglia R; Burlina S; Bolis A; Marin R; Manzato E; Ragazzi E; Traldi P; Lapolla A Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):418-25. PubMed ID: 25636381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]